| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| FRA16D |
|
fragile site, aphidicolin type, common, fra(16)(q23.2)
|
|
|
0.656 |
0.577 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| PTMAP4 |
|
prothymosin alpha pseudogene 4
|
|
|
0.638 |
0.731 |
| SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| LINC00312 |
Q9Y6C7
|
long intergenic non-protein coding RNA 312
|
|
|
0.711 |
0.385 |
| TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
| ANKRD36B |
Q8N2N9
|
ankyrin repeat domain 36B
|
|
|
0.584 |
0.500 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| FRTS1 |
|
Fanconi renotubular syndrome
|
|
|
0.599 |
0.654 |
| PPP1R2C |
O14990
|
PPP1R2C family member C
|
Enzyme modulator
|
|
0.478 |
0.846 |
| FOXD2-AS1 |
|
FOXD2 adjacent opposite strand RNA 1
|
|
|
0.644 |
0.423 |
| SNHG7 |
|
small nucleolar RNA host gene 7
|
|
|
0.619 |
0.500 |
| CYTOR |
|
cytoskeleton regulator RNA
|
|
|
0.568 |
0.577 |
| CBLL2 |
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
|
0.476 |
0.808 |
| CASC2 |
|
cancer susceptibility 2
|
|
|
0.612 |
0.462 |
| NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| LINC01194 |
|
long intergenic non-protein coding RNA 1194
|
|
|
0.470 |
0.769 |